Home/Filings/4/0001437749-23-028700
4//SEC Filing

FINE N SCOTT 4

Accession 0001437749-23-028700

CIK 0000922247other

Filed

Oct 22, 8:00 PM ET

Accepted

Oct 23, 6:05 AM ET

Size

9.1 KB

Accession

0001437749-23-028700

Insider Transaction Report

Form 4
Period: 2023-10-20
FINE N SCOTT
Director
Transactions
  • Exercise of In-Money

    Common Stock

    2023-10-20$0.71/sh+299,402$212,575743,804 total
  • Exercise of In-Money

    Warrant to Purchase Common Stock

    2023-10-20$0.13/sh299,402$37,4250 total
    Exercise: $0.71From: 2023-04-20Exp: 2030-04-20Common Stock (299,402 underlying)
  • Purchase

    Warrant to Purchase Common Stock

    2023-10-20+329,342329,342 total
    Exercise: $0.95From: 2023-10-20Exp: 2027-10-20Common Stock (329,342 underlying)
Footnotes (1)
  • [F1]The Reporting Person exercised vested Warrants (the "Original Warrants") to purchase 299,402 shares of the Issuer's common stock pursuant to a Securities Purchase Agreement dated October 20, 2023 ("Closing Date"). The Reporting Person exercised his Original Warrant in full on or prior to the Closing Date in consideration of the receipt of new warrants with an exercise price equal to $0.95 per share, to purchase 110% of the shares of the Issuer's common stock covered under the Original Warrants.

Issuer

Cyclo Therapeutics, Inc.

CIK 0000922247

Entity typeother

Related Parties

1
  • filerCIK 0001163556

Filing Metadata

Form type
4
Filed
Oct 22, 8:00 PM ET
Accepted
Oct 23, 6:05 AM ET
Size
9.1 KB